Cargando…
Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future
Renal cell carcinoma (RCC) is the most lethal of all urologic malignancies. Recent translational research in RCC has led to the discovery of a new class of therapeutics that specifically target important signaling molecules critical in the pathogenesis of the disease. It is now clear that these new...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808643/ https://www.ncbi.nlm.nih.gov/pubmed/19955664 http://dx.doi.org/10.4103/0970-1591.57899 |